Premium Listings

Staying competitive is in sharp focus for the United Kingdom in a post-Brexit world. The saga unfolding at NMC Health, a FTSE100 business, was well outlined in an opinion piece in the Financial Times earlier this week. Those who remember the outrage surrounding behaviour at Eurasian Natural Resources Corporation (ENRC) for example – and the negative publicity around the premium listing, will point to the tightening of the governance rules in response as decisive action taken.

This week, as NMC Health hits the deadlines on a daily basis and its share price gyrates with speculation, the premium listing standards are again in the spotlight. “UK regulators have already shown a recent willingness to water down standards to attract overseas business…. NMC Health’s issues are a timely reminder of just how badly things can go wrong” writes Brooke Masters in the FT. Anyone who cares about corporate governance will be watching closely.